Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
europe blog main
3
×
life sciences
national blog main
national top stories
boston blog main
boston top stories
cancer
eli lilly
europe top stories
fda
indiana blog main
indiana top stories
national
new york blog main
novartis
san francisco blog main
san francisco top stories
abbvie
accent therapeutics
aducanumab
allergan
alzheimer's disease
amblyotech
amgen
asklepios biopharmaceutical
avapritinib
bioeurope
biogen
biohaven
biomarin pharmaceutical
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer drugs
capmatinib
cara therapeutics
What
fda
3
×
medicines
3
×
new
activity
address
adults
allergan
approval
approvals
approved
approves
bio
biogen
blueprint
cancer
carries
certain
clamped
class
covid
delays
designed
developing
drug
economic
fast
genetic
including
ipo
isn’t
latest
lot
migraine
monday
nod
oric’s
pass
pill
ret
roundup
Language
unset
Current search:
medicines
×
photo
×
fda
×
" europe blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines